The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Looking good for a re-rate upwards now,,,
Craig Gulliford, Chief Executive Officer of Creo, commented:
"We are delighted to receive FDA clearance for the MicroBlate™ Flex device and we remain focussed on completing our programme of regulatory clearances for the full suite of advanced energy surgery products for the flexible endoscopy market. We expect to see further first clinical use of our products in various markets and we look forward to utilising our enhanced global sales and marketing capability to drive commercialisation of our range."
Price History
Average Volume (10 day) 2.545M
today is so far 6.572 M
source: Trading View.com
My goodness there's a lot of interest,,,,
more upwards movement to come...
David Price, Chief Executive Officer of Rockfire says it all really... Excellent news.
Great!!
Intercede, the leading specialist in digital identities, credential management and secure mobility, is pleased to announce a new contract win with a large US defence contractor. The initial order totaling $0.2m includes MyID Enterprise software licenses plus associated support & maintenance and professional services.
This contract win is noteworthy, not only because another top 10 US defence contractor has selected MyID to help secure their mission critical assets, but also due to the short lead time involved which was less than three months from initial Partner introduction to receipt of order.
The lender, whose stock has fallen 68% this year, said it would pay an reduced interim dividend of one penny per share.
For balance and fairness ....and on the other side of the coin using both eyes wide open...
Morses Club's MCLM.L first-half profit fell 76%
First-half revenues also dropped by 24%
Interim results for the 26 weeks ended 29 August 2020.
Look awful.
great news...
REG - DeepMatter Group PLC - Multi-year contract with Thieme Chemistry
signed a three-year contract with Thieme Chemistry, which is part of the Thieme Group, an award-winning international medical and science publisher serving health professionals and students for more than 130 years, for the supply of technical data services and access to the Group's proprietary algorithms.
The contract builds on a long-standing relationship between the two businesses, providing Thieme with access to DeepMatter's services and algorithms to ensure the quality of, and access to, their data.
Excellent!!
https://www.trustintelligence.co.uk/articles/fund-profile-us-solar-fund-dec-2020
Very positive.
I'm in.
Some cheer now and ahead.
First clinical use of new Creo GI product. This is great news.
Goodish....
Revenues increased significantly, up 38% quarter on quarter
Average grade increased by 3.3% qoq.
The company has been granted a supplementary credit line of KZT 3bn (~USD 7m)
from Kazakh Bank JSC “Bank Center Credit” (BCC). The loan is repayable in instalments over a term of five years and bears an interest rate of 6%. The loan will be used to increase processing plant output in line with the company’s plans.
a lot of ''falls'' , ''declines'', ''reduced''.
Great RNS. Onwards and upwards....
you have to offer more then!